Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion
i
Other names:
IDH2, Isocitrate Dehydrogenase (NADP(+)) 2, Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial, Isocitrate Dehydrogenase 2 (NADP+), Mitochondrial, Isocitrate Dehydrogenase [NADP], Mitochondrial, Oxalosuccinate Decarboxylase, NADP(+)-Specific ICDH, ICD-M, IDH, IDP, MNADP-IDH, D2HGA2, IDHM, IDPM, NTRK1, MTC, TRK, TRKA, Neurotrophic tyrosine kinase, receptor, type 1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4914
;
3418
Related biomarkers:
Expression
Mutation
Fusion
Others
‹
NTRK1 positive (2)
NTRK1 overexpression (1)
IDH2 overexpression (0)
NTRK1 positive (2)
NTRK1 overexpression (1)
IDH2 overexpression (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion
Oligodendroglioma
IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion
Oligodendroglioma
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion
Oligodendroglioma
IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion
Oligodendroglioma
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.